PetMed Express, Inc. reported significant financial challenges in its latest 10-Q filing for the quarter ending September 30, 2025. The company recorded net sales of $44.4 million, a decrease of 23.6% compared to $58.0 million in the same quarter of the previous year. For the six months ending September 30, 2025, total sales were $95.5 million, down 23.1% from $124.3 million in the prior year. The decline in revenue was attributed to reduced advertising effectiveness, increased consumer promotional usage, and a drop in prescription medication sales. The company also reported a net loss of $8.5 million for the quarter, compared to a net income of $2.3 million in the same period last year.

The financial performance reflects a broader trend of declining customer engagement, with the company acquiring approximately 58,000 new customers in the latest quarter, down from 77,000 in the same quarter last year. The total number of new customers for the six months was 143,000, a decrease from 197,000 in the prior year. The average purchase amount remained relatively stable at approximately $98, indicating that while fewer customers are engaging, those who do are spending similar amounts.

Operationally, PetMed Express faced increased costs, with cost of sales rising to 72.0% of total sales for the quarter, compared to 67.7% in the previous year. This increase was primarily due to higher discount activity and freight costs. General and administrative expenses surged by 35.1% to $14.2 million for the quarter, driven by increased professional fees related to a whistleblower investigation. Advertising expenses also decreased significantly, reflecting a strategic shift in marketing spend, which was down 28.5% to $4.3 million for the quarter.

Looking ahead, the company expressed concerns about the impact of macroeconomic factors such as inflation and rising interest rates on consumer behavior and spending patterns. PetMed Express is focusing on improving operational efficiency and managing costs to navigate these challenges. The company has also suspended its quarterly dividend to allocate resources towards growth initiatives. Despite the current difficulties, management remains committed to evaluating strategic opportunities, including potential acquisitions, to enhance shareholder value.

About PETMED EXPRESS INC

PetMed Express, Inc. is a leading direct-to-consumer pet pharmacy offering prescription and non-prescription medications, food, supplements, and supplies for dogs, cats, and horses. Through its brands PetMeds and PetCareRx, it provides online sales, telehealth, pet insurance, and veterinary partnerships across North America. The company emphasizes quality, regulatory compliance, customer support, and innovative digital platforms to serve pet owners and promote pet wellness.

This description was generated via AI from an annual report. Updated 10 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.